317 related articles for article (PubMed ID: 30708099)
1. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
[TBL] [Abstract][Full Text] [Related]
2. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
[TBL] [Abstract][Full Text] [Related]
3. All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element.
Tamaki M; Tominaga T; Fujita Y; Koezuka Y; Ichien G; Murakami T; Kishi S; Yamamoto K; Abe H; Nagai K; Doi T
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E418-E431. PubMed ID: 30601699
[TBL] [Abstract][Full Text] [Related]
4. Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy.
Tominaga T; Abe H; Ueda O; Goto C; Nakahara K; Murakami T; Matsubara T; Mima A; Nagai K; Araoka T; Kishi S; Fukushima N; Jishage K; Doi T
J Biol Chem; 2011 Jun; 286(22):20109-16. PubMed ID: 21471216
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy.
Mima A; Matsubara T; Arai H; Abe H; Nagai K; Kanamori H; Sumi E; Takahashi T; Iehara N; Fukatsu A; Kita T; Doi T
Lab Invest; 2006 Sep; 86(9):927-39. PubMed ID: 16767106
[TBL] [Abstract][Full Text] [Related]
6. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
[TBL] [Abstract][Full Text] [Related]
7. SOX9 protein induces a chondrogenic phenotype of mesangial cells and contributes to advanced diabetic nephropathy.
Kishi S; Abe H; Akiyama H; Tominaga T; Murakami T; Mima A; Nagai K; Kishi F; Matsuura M; Matsubara T; Iehara N; Ueda O; Fukushima N; Jishage K; Doi T
J Biol Chem; 2011 Sep; 286(37):32162-9. PubMed ID: 21795715
[TBL] [Abstract][Full Text] [Related]
8. Camel milk attenuates the biochemical and morphological features of diabetic nephropathy: inhibition of Smad1 and collagen type IV synthesis.
Korish AA; Abdel Gader AG; Korashy HM; Al-Drees AM; Alhaider AA; Arafah MM
Chem Biol Interact; 2015 Mar; 229():100-8. PubMed ID: 25617480
[TBL] [Abstract][Full Text] [Related]
9. Role of Smad1 in diabetic nephropathy: Molecular mechanisms and implications as a diagnostic marker.
Abe H; Matsubara T; Arai H; Doi T
Histol Histopathol; 2011 Apr; 26(4):531-41. PubMed ID: 21360446
[TBL] [Abstract][Full Text] [Related]
10. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
[TBL] [Abstract][Full Text] [Related]
11. [Recent progress in understanding the molecular pathogenesis of diabetic nephropathy].
Abe H
Rinsho Byori; 2011 Feb; 59(2):179-86. PubMed ID: 21476304
[TBL] [Abstract][Full Text] [Related]
12. Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle α-actin (SMA) signal transduction in diabetic nephropathy.
Abe H; Tominaga T; Matsubara T; Abe N; Kishi S; Nagai K; Murakami T; Araoka T; Doi T
J Biol Chem; 2012 Jun; 287(24):20430-42. PubMed ID: 22474292
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.
Li Z; Zhang H; Dong X; Burczynski FJ; Choy P; Yang F; Liu H; Li P; Gong Y
Biochem Cell Biol; 2010 Aug; 88(4):635-48. PubMed ID: 20651835
[TBL] [Abstract][Full Text] [Related]
14. Transcription factor 7-like 2 (TCF7L2) regulates activin receptor-like kinase 1 (ALK1)/Smad1 pathway for development of diabetic nephropathy.
Araoka T; Abe H; Tominaga T; Mima A; Matsubara T; Murakami T; Kishi S; Nagai K; Doi T
Mol Cells; 2010 Sep; 30(3):209-18. PubMed ID: 20803090
[TBL] [Abstract][Full Text] [Related]
15. Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.
Wu P; Wang Y; Davis ME; Zuckerman JE; Chaudhari S; Begg M; Ma R
J Am Soc Nephrol; 2015 Nov; 26(11):2691-702. PubMed ID: 25788524
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of Smad1 pathway and collagen IV expression by store-operated Ca
Wu P; Ren Y; Ma Y; Wang Y; Jiang H; Chaudhari S; Davis ME; Zuckerman JE; Ma R
Am J Physiol Renal Physiol; 2017 Jun; 312(6):F1090-F1100. PubMed ID: 28298362
[TBL] [Abstract][Full Text] [Related]
17. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
[TBL] [Abstract][Full Text] [Related]
18. Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.
Abe H; Matsubara T; Iehara N; Nagai K; Takahashi T; Arai H; Kita T; Doi T
J Biol Chem; 2004 Apr; 279(14):14201-6. PubMed ID: 14732718
[TBL] [Abstract][Full Text] [Related]
19. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
